Here are sales figures for the first quarter for top-selling Pfizer prescription drugs:
PRODUCT NAME MAIN CONDITION/USE 1Q 2011 SALES 1Q 2010 SALES PERCENT CHANGE
Lipitor High cholesterol $1.4 billion $2.4 billion down 42 percent
Lyrica Fibromyalgia/pain $955 million $826 million up 16 percent
Enbrel (outside U.S.) Rheumatoid arthritis $899 million $870 million up 3 percent
Prevnar 7/Prevnar 13 Pneumococcal vaccine $1.08 billion $1.15 billion down 6 percent
Celebrex Pain $634 million $591 million up 7 percent
Viagra Erectile dysfunction $496 million $470 million up 6 percent
Norvasc High blood pressure $334 million $356 million down 6 percent
Zyvox MRSA infections $325 million $319 million up 2 percent
Sutent Multiple cancers $300 million $276 million up 9 percent
Premarin/Prempro Menopause symptoms $261 million $235 million up 11 percent
___
Source: Pfizer Inc.
